Related Experiment Video
Updated: Jul 19, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
[Antiviral therapy: from influenza to Pfeiffer's disease]
1Infektiologie, Klinik und Poliklinik I für Innere Medizin, Universitätsklinikum, Regensburg. bernd.salzberger@klinik.uni-r.de
Abstract:
Antiviral drug therapy has rapidly evolved in recent years. A large number of specific inhibitors against newly detected viral targets has been developed. Viral infections except HIV and viral hepatitis infections are clinically relevant mostly in severely immunocompromised patients. Especially respiratory viral infections and herpes virus infections are associated with high morbidity and mortality in these patients. Therapeutic and preventive strategies have been developed for a number of these infections. There is high priority for the development of new substances for a number of viruses not yet treatable and substances active against resistant viral strains.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Respiratory Syncytial Virus Disease
Influenza
Inhibitors of Virion Maturation and Assembly

